Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 87
12
Diseases
84
Unique genes
0.129
Avg. similarity score
Antisocial personality disorder
Most-connected disease (7 links)
Disease
Searched: Conduct disorder
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Conduct disorder
Antisocial personality disorder
Colchicine resistance
Familial mediterranean fever
Orthostatic hypotension
Congenital dyserythropoietic anemia
Hematologic neoplasms
Hyperpituitarism
Separation anxiety disorder
Brunner syndrome
Dopamine beta-hydroxylase deficiency
severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Antisocial personality disorder | 7 | 7 | 4 |
| Colchicine resistance | 6 | 6 | 1 |
| Familial mediterranean fever | 6 | 6 | 2 |
| Orthostatic hypotension | 5 | 5 | 3 |
| Congenital dyserythropoietic anemia | 4 | 4 | 10 |
| Conduct disorder | 3 | 3 | 52 |
| Hematologic neoplasms | 3 | 3 | 5 |
| Hyperpituitarism | 3 | 3 | 15 |
| Separation anxiety disorder | 2 | 2 | 1 |
| Brunner syndrome | 1 | 1 | 1 |
| Dopamine beta-hydroxylase deficiency | 1 | 1 | 2 |
| severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| ABCB1 | 7 / 12 | Antisocial personality disorder, Colchicine resistance, Congenital dyserythropoietic anemia, Familial mediterranean fever and 3 more |
| DRD4 | 3 / 12 | Antisocial personality disorder, Conduct disorder, Separation anxiety disorder |
| GATAD2B | 2 / 12 | Conduct disorder, severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome |
| HSPA5 | 2 / 12 | Dopamine beta-hydroxylase deficiency, Hematologic neoplasms |
| HTR1B | 2 / 12 | Antisocial personality disorder, Conduct disorder |
| MAD1L1 | 2 / 12 | Conduct disorder, Hyperpituitarism |
| MAOA | 2 / 12 | Antisocial personality disorder, Brunner syndrome |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Tyrosine metabolism | KEGG | 4 / 36 | 15.9× | 1.11e-4 | 2.37e-3 ✓ sig. |
| Ethanol oxidation | Reactome | 2 / 12 | 23.8× | 3.05e-3 | 3.09e-2 ✓ sig. |
| Fatty acid degradation | KEGG | 3 / 43 | 10.0× | 3.33e-3 | 3.29e-2 ✓ sig. |
| Defective MAOA causes Brunner syndrome (BRUNS) | Reactome | 1 / 1 | 143× | 6.99e-3 | 5.47e-2 |
| Receptor-type tyrosine-protein phosphatases | Reactome | 2 / 20 | 14.3× | 8.46e-3 | 6.23e-2 |
| Synaptic adhesion-like molecules | Reactome | 2 / 21 | 13.6× | 9.31e-3 | 6.62e-2 |
| Enzymatic degradation of Dopamine by monoamine oxidase | Reactome | 1 / 2 | 71.5× | 1.39e-2 | 8.48e-2 |
| Metabolism of serotonin | Reactome | 1 / 2 | 71.5× | 1.39e-2 | 8.48e-2 |
| Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB | Reactome | 1 / 2 | 71.5× | 1.39e-2 | 8.48e-2 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | Reactome | 1 / 2 | 71.5× | 1.39e-2 | 8.48e-2 |
| Drug metabolism - cytochrome P450 | KEGG | 3 / 73 | 5.9× | 1.44e-2 | 8.68e-2 |
| Mitotic Telophase/Cytokinesis | Reactome | 1 / 3 | 47.7× | 2.08e-2 | 1.07e-1 |
| Enzymatic degradation of dopamine by COMT | Reactome | 1 / 3 | 47.7× | 2.08e-2 | 1.07e-1 |
| IRE1alpha activates chaperones | Reactome | 1 / 3 | 47.7× | 2.08e-2 | 1.07e-1 |
| RUNX2 regulates osteoblast differentiation | Reactome | 1 / 3 | 47.7× | 2.08e-2 | 1.07e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | GO:0007187 | 5 / 54 | 20.6× | 4.33e-6 | 2.69e-4 ✓ sig. |
| behavioral response to ethanol | GO:0048149 | 3 / 10 | 66.7× | 1.03e-5 | 5.37e-4 ✓ sig. |
| regulation of chloride transport | GO:2001225 | 2 / 4 | 111× | 1.19e-4 | 3.45e-3 ✓ sig. |
| erythrocyte differentiation | GO:0030218 | 4 / 65 | 13.7× | 2.09e-4 | 5.22e-3 ✓ sig. |
| cellular response to alkaloid | GO:0071312 | 2 / 6 | 74.2× | 2.96e-4 | 6.69e-3 ✓ sig. |
| cell surface receptor protein tyrosine phosphatase signaling pathway | GO:0007185 | 2 / 7 | 63.6× | 4.13e-4 | 8.45e-3 ✓ sig. |
| fear response | GO:0042596 | 2 / 8 | 55.6× | 5.49e-4 | 1.03e-2 ✓ sig. |
| chemical synaptic transmission | GO:0007268 | 6 / 236 | 5.7× | 6.81e-4 | 1.19e-2 ✓ sig. |
| G protein-coupled opioid receptor signaling pathway | GO:0038003 | 2 / 9 | 49.4× | 7.04e-4 | 1.21e-2 ✓ sig. |
| negative regulation of cytosolic calcium ion concentration | GO:0051481 | 2 / 11 | 40.4× | 1.07e-3 | 1.58e-2 ✓ sig. |
| mitotic spindle midzone assembly | GO:0051256 | 2 / 11 | 40.4× | 1.07e-3 | 1.58e-2 ✓ sig. |
| dopamine catabolic process | GO:0042420 | 2 / 11 | 40.4× | 1.07e-3 | 1.58e-2 ✓ sig. |
| cerebellar Purkinje cell layer development | GO:0021680 | 2 / 12 | 37.1× | 1.28e-3 | 1.76e-2 ✓ sig. |
| maternal behavior | GO:0042711 | 2 / 14 | 31.8× | 1.75e-3 | 2.14e-2 ✓ sig. |
| detection of mechanical stimulus | GO:0050982 | 2 / 15 | 29.7× | 2.02e-3 | 2.31e-2 ✓ sig. |